'Groundbreaking' Results With Nasal Spray for Home Tachycardia Conversion

(MedPage Today) -- CHICAGO -- The investigational L-type calcium channel blocker etripamil, formulated as a self-administered nasal spray, shortened spontaneous paroxysmal supraventricular tachycardia episodes among patients in at-home settings...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news